Your browser doesn't support javascript.
loading
Progressive supranuclear palsy: diagnosis and management.
Rowe, James B; Holland, Negin; Rittman, Timothy.
Afiliação
  • Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, Cambridgeshire, UK james.rowe@mrc-cbu.cam.ac.uk.
  • Holland N; MRC Cognition and Brain Sciences Unit, Cambridge, Cambridgeshire, UK.
  • Rittman T; Department of Clinical Neurosciences, University of Cambridge, Cambridge, Cambridgeshire, UK.
Pract Neurol ; 21(5): 376-383, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34215700
ABSTRACT
Treating patients with progressive supranuclear palsy (PSP) is both effective and rewarding. This review aims to share our experience in the proactive management of PSP, considering the patient, the family and the medical context in which the illness unfolds. There are many opportunities to assist your patients, ameliorate their symptoms, reduce their risks and harm, and guide them through the complex medical, social and legal minefield that characterises life with chronic neurological illness. We summarise the challenges of early diagnosis, consider PSP mimics and the role of investigations in excluding these, and discuss the available pharmacological and non-pharmacological treatment strategies to tackle the common and challenging symptoms of PSP. The best treatment will be patient centred and as part of a multidisciplinary team.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paralisia Supranuclear Progressiva Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paralisia Supranuclear Progressiva Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article